Texas Gov. Greg Abbott on June 11 signed a bill creating a consortium of universities, hospitals and pharmaceutical firms to conduct clinical trials on ibogaine, in hopes of receiving US Food & Drug Administration approval. The press release on the signing hails ibogaine as an "emerging treatment for neurological and mental health conditions." Lawmakers approved $50 million to support the effort, making Texas the global leader in psychedelic research investment. (Texas Tribune)
Recent comments
1 day 6 hours ago
6 days 14 hours ago
10 weeks 6 days ago
15 weeks 35 min ago
16 weeks 11 hours ago
16 weeks 14 hours ago
37 weeks 1 day ago
41 weeks 2 days ago
42 weeks 6 days ago
43 weeks 43 min ago